nivolumab
bms
['cm-816']
dr janis taube presents pathologic features and efficacy outcomes from cm-816 trial. #esmo22 
Thoracic Medical Oncologist @lombardicancer, Assistant Professor @Georgetown. Interested in immunotherapy translational clinical trials. Opinions are my own.